Status:
COMPLETED
Evaluation of Pre-exposure Prophylaxis Cascade in Pregnant and Breastfeeding Women in Cape Town (Formative Study)
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
University of Cape Town
Desmond Tutu HIV Foundation
Conditions:
Hiv
Eligibility:
FEMALE
16+ years
Phase:
PHASE4
Brief Summary
The overarching goal of this proposal is to evaluate the feasibility and acceptability of integrating PrEP into antenatal and postnatal care, to describe the cascade in women initiating PrEP in this s...
Eligibility Criteria
Inclusion
- Documented HIV-negative according to two fingerpick rapid tests (per routine antenatal care protocol in this setting), confirmed with a 4th generation antigen HIV test at study enrollment
- No previous exposure triple-drug antiretroviral therapy
- Age 18 years or older
- Lives within 20 kilometers of a clinic
- Without psychiatric or medical contraindications to PrEP use
- Able to provide informed consent for research
Exclusion
- Failure to meet any of the inclusion criteria
Key Trial Info
Start Date :
August 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03826199
Start Date
August 23 2019
End Date
September 30 2023
Last Update
December 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gugulethu Midwife Obstetric Unit
Cape Town, South Africa